Ilika confirms AGM date and Annual Report posting

IKA

Ilika Plc (LON:IKA), a pioneer in solid state battery technology, has given formal notice that its Annual General Meeting will be held on Tuesday, 22 September 2026 at 2.00 pm (BST) at the offices of Eversheds Sutherlands LLP, One Wood Street, London EC2V 7WS.

If you wish to attend the AGM in your capacity as a shareholder, please bring proof of shareholding or, if shares are held through a nominee account, a letter of representation, to facilitate your entry to the Meeting. If you are not planning to attend the meeting and would like someone else to vote for you at the meeting (or any adjournment of the meeting), please complete the form of proxy, which can be accessed using the following link www.investorcentre.co.uk/eproxy

Shareholders are encouraged to appoint the Chairman of the Meeting as their proxy with their voting instructions. Please vote online at www.investorcentre.co.uk/eproxy and enter the Control Number, your Shareholder Reference Number (SRN), and PIN as shown on the Proxy Form.

To be valid, proxy appointments for the AGM must be received by the Company’s Registrar, Computershare Investor Services PLC, no later than 2.00 pm (BST) on Friday 18 September 2026.

Posting of Annual Report and AGM Notice

The Company confirms that the Annual Report and Accounts for the year ended 30 April 2026 and the Notice of the 2026 AGM will be made available shortly to view or download by clicking the links below.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika confirms AGM date and Annual Report posting

Ilika has given notice of its 2026 Annual General Meeting and said its annual report and AGM notice will be available shortly.

Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices.

Ilika advances Goliath towards commercial deployment

Ilika is advancing Goliath through testing and manufacturing scale-up while targeting shorter-cycle markets alongside longer-term electric vehicle adoption.

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production.

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.

Search